S100A9 and inflammatory bowel disease: The combination of epigenetics and transcriptomics revealed that the S100A9 gene in the gut of inflammatory bowel disease (IBD) patients is characterized by high DNA methylation and low RNA expression, and was identified as a new diagnostic marker [15].